Skip to content

Study on The Effect and Mechanism of Magnanimous Maintenance therapy on Depression and Anxiety in Young People

Study on The Effect and Mechanism of Magnanimous Maintenance therapy on Depression and Anxiety in Young People

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059092
Enrollment
Unknown
Registered
2022-04-24
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Single courses of Magnanimous treatment group:Single courses of Magnanimous treatment group
Two courses of Magnanimous treatment group:Two courses of Magnanimous treatment
Three courses of Magnanimous treatment group:Three courses of Magnanimous treatment
Supportive treatment group:Supportive treatment
Blank control group:None

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
15 Years to 28 Years

Inclusion criteria

Inclusion criteria: 1. Young people with symptoms of depression and anxiety were selected; 2. SDS standard score >=50 (that is, more than mild depression); 3. SAS standard score >=50 points (that is, mild anxiety above); 4. Young people aged between 15 and 28; 5. Patients voluntarily participated in the study and signed informed consent;

Exclusion criteria

Exclusion criteria: 1. Patients with brain organic diseases and serious physical diseases; 2. Laboratory examination of patients with severe abnormalities; 3. People with bidirectional disorder and serious suicidal tendency; 4. Patients with severe psychoactive substance abuse; 5. Those who cannot accept psychological treatment.

Design outcomes

Primary

MeasureTime frame
Beck Depression Scale;Beck Anxiety Scale;Mental resilience scale;Social support Rating Scale;Symptom self-rating Scale;Aggressive and open-minded questionnaire;

Countries

China

Contacts

Public ContactHuang Xuewei

The First Affiliated Hospital of Guangdong Pharmaceutical University

407144104@qq.com+86 13430398753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026